Switzerland’s Novartis AG (NOVN.VX: Quote, Profile, Research) is watching developments at drugmaker Aventis SA (AVEP.PA: Quote, Profile, Research) but is wary about entering an all-French takeover battle, people familiar with the situation said on Thursday.
